BioHealth News Archive
Emergent BioSolutions Adding Approximately 300 Jobs After New COVID-19 Vaccine Contracts
Business is booming for Emergent BioSolutions as it has assisted in the country’s push to create COVID-19 treatments and vaccines. Emergent is developing two…
Read MoreEmergent BioSolutions Enters Viral Vector And Gene Therapy Arena – Contract Pharma
Emergent BioSolutions has unveiled plans to strengthen its contract development and manufacturing (CDMO) capabilities by expanding into viral vector and gene therapy. The company…
Read MoreLockheed’s ventures arm backs quantum computing and training tech firms — Washington Technology
Lockheed Martin Ventures -- the defense company’s technology startup investment arm -- has backed two companies through separate avenues announced this week. In a…
Read MoreGlyscend Therapeutics Completes $20.5M Financing Round to Advance Novel Oral Polymer Therapy for Type 2 Diabetes
BALTIMORE, June 11, 2020 (GLOBE NEWSWIRE) -- Glyscend Therapeutics, a privately held biopharmaceutical company developing novel treatments for type 2 diabetes (T2D) and related…
Read MoreBioHealth Capital Region Spotlighted at RESI
The BioHealth Capital Region featured at last week’s Redefining Early Stage Investments Conference (RESI) where speakers from the region discussed a range of topics…
Read MoreCreatv Announces Ability to Predict Immunotherapy Treatment Response for Non-Small Cell Lung Cancer (NSCLC) using a Simple Blood Test | Business Wire
ROCKVILLE, Md.--(BUSINESS WIRE)--Creatv Microtech, a privately-held biotechnology company has pioneered a blood test to predict treatment response in patients with stage II-III NSCLC treated…
Read MoreFina Biosolutions Receives SBIR Matching Grant from Montgomery County, MD
Fina Biosolutions recently received a $25,000 Montgomery County SBIR/STTR Phase I matching grant to support its NIH SBIR grant focused on “Genetically detoxified tetanus…
Read MoreWe shouldn’t care who wins the vaccine ‘race’ – The Washington Post
Regarding the June 4 front-page article “Cold War echoes in race for vaccine,” about the “race” among nations, notably the United States, China, and…
Read MoreProducing Enough Vaccine For The Coronavirus Means Companies Have To Start Now : Shots – Health News : NPR
Once upon a time, developing a new vaccine was a step-by-step process that went from concept, to design, to tests in humans, to regulatory…
Read MoreNIH announces $1 million prize competition to target global disease diagnostics
The National Institutes of Health has launched a $1 million Technology Accelerator Challenge (TAC) to spur the design and development of non-invasive, handheld, digital…
Read MoreCan you catch Covid-19 from someone without symptoms? — Quartz
On Monday, June 8, an official at the World Health Organization (WHO) made a surprising statement. People who have Covid-19 but are asymptomatic—meaning they…
Read MoreKaloCyte raises $300K from Maryland Momentum Fund – Technical.ly Baltimore
Less than a year after relocating its headquarters to Baltimore, biotech company KaloCyte has raised new funding from Maryland-based investors and expanded its local team.…
Read MorePathSensors Inc. Announced the Completion of Phase I of a SBIR
PathSensors Inc., a Baltimore biotechnology company, announced today the completion of Phase I of a Small Business Innovation Research (SBIR) program funded by the…
Read MoreCovid-19 vaccine price controls would scare off developers, Fauci says at BIO – MedCity News
As multiple companies work to develop vaccines against the virus that causes Covid-19, it will be important for them to work with the federal…
Read MoreJohns Hopkins to resume on-campus lab research next week | Hub
Johns Hopkins University researchers will be permitted to resume on-site laboratory activities beginning next week, the first steps of a gradual resumption of on-campus…
Read More